Compare · ACAX vs CAH
ACAX vs CAH
Side-by-side comparison of Alset Capital Acquisition Corp. (ACAX) and Cardinal Health Inc. (CAH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ACAX and CAH operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- CAH carries a market cap of $14.83B.
- CAH has hit the wire 2 times in the past 4 weeks while ACAX has been quiet.
- CAH has more recent analyst coverage (25 ratings vs 0 for ACAX).
- Company
- Alset Capital Acquisition Corp.
- Cardinal Health Inc.
- Price
- $3.85-63.71%
- $199.83-2.42%
- Market cap
- -
- $14.83B
- 1M return
- -
- -5.45%
- 1Y return
- -
- +44.55%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 0
- 2
- Recent ratings
- 0
- 25
Alset Capital Acquisition Corp.
Alset Capital Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on identifying businesses in the real estate industry, including construction, homebuilding, real estate owners and operators, arrangers of financing, insurance, and other services for real estate, as well as businesses and technologies targeting the real estate space. The company was incorporated in 2021 and is based in Bethesda, Maryland.
Cardinal Health Inc.
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
Latest ACAX
- SEC Form SC 13G filed by Alset Capital Acquisition Corp.
- SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form 8-K filed by Alset Capital Acquisition Corp.
- SEC Form SC 13D/A filed by Alset Capital Acquisition Corp. (Amendment)
- SEC Form SC 13G filed by Alset Capital Acquisition Corp.
Latest CAH
- SEC Form 4 filed by Hall Patricia Hemingway
- Cardinal Health report highlights growing momentum to expand advanced therapies into community care settings
- Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapies
- Amendment: SEC Form SCHEDULE 13G/A filed by Cardinal Health Inc.
- Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2026 on April 30
- Cardinal Health Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Cardinal Health Appoints Patricia A. Hemingway Hall as Board Chair
- Cardinal Health Inc. filed SEC Form 8-K: Leadership Update
- Chief Information Officer Greene Michelle D. sold $627,387 worth of shares (2,746 units at $228.47), decreasing direct ownership by 18% to 12,230 units (SEC Form 4)
- Cardinal Health report highlights cost savings and provider confidence in biosimilars